Pentoxifylline inhibits Ig κ gene transcription and rearrangements in Pre-B cells

Journal of Immunology

Volumn 160, Issue 4, 1998, Pages 1789-1795

  Wang, Weihong ^a   Rath, Satyajit ^b   Durdik, Jeannine M ^c   Sen, Ranjan ^a  

^a BRANDEIS UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^c UNIVERSITY OF ARKANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN KAPPA CHAIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; PENTOXIFYLLINE; RECOMBINANT INTERLEUKIN 4;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL LINE; CONTROLLED STUDY; GENE REARRANGEMENT; GENETIC RECOMBINATION; GENETIC TRANSCRIPTION; IMMUNOGLOBULIN GENE; NONHUMAN; PRIORITY JOURNAL; PROLYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINE; GENE EXPRESSION REGULATION; GENE REARRANGEMENT, B-LYMPHOCYTE; GENES, IMMUNOGLOBULIN; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; INTERLEUKIN-4; MICE; PENTOXIFYLLINE; STEM CELLS; TRANSCRIPTION, GENETIC;

EID: 0032519688     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Streiter, R. M., D. G. Remick, P. A. Ward, R. N. Spengler, J. P. Lynch, J. Larrick, and S. L. Kunkel. 1988. Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem. Biophys. Res. Commun. 155:1230.
2. Bellas, R. E., J. S. Lee, and G. E. Sonenshein. 1995. Expression of a constitutive NF-kappa B-like activity is essential for proliferation of culture bovine vascular smooth muscle cells. J. Clin. Invest. 96:2521.
3. Biswas, D. K., B. J. Dezube, C. M. Ahlers, and A. B. Pardee. 1993. Pentoxifylline inhibits HIV-1 LTR-driven gene expression by blocking NF-kappa B action. J. Acquired Immune Defic. Syndr. 6:778.
4. Kovach, N. L., C. G. Lindgren, A. Fefer, J. A. Thompson, T. Yednock, and J. M. Harlan. 1994. Pentoxifylline inhibits integrin-mediated adherence of interleukin-2-activated human peripheral blood lymphocytes to human umbilical vein endothelial cells, matrix components, and culture tumor cells. Blood 84:2234.
5. Takahashi, G. W., R. B. Montgomery, W. L. Stahl, C. A. Crittenden, M. A. Valentine, D. R. Thorning, D. V. Andrews, and M. B. Lilly. 1994. Pentoxifylline inhibits tumor necrosis factor-alpha-mediated cytotoxicity and cytostasis in L929 murine fibrosarcoma cells. Int. J. Immunopharmacol. 16:723.
6. Tozawa, K., S. Sakurada, K. Kohri, and T. Okamoto. 1995. Effects of anti-nuclear factor kappa B reagents in blocking adhesion of human cancer cells to vascular endothelial cells. Cancer Res. 55:4162.
7. Wang, W., W. F. Tam, C. C. W. Hughes, S. Rath, and R. Sen. 1997. Immunity c-Rel is a target of pentoxifylline-mediated inhibition of T lymphocyte activation. Immunity 6:165.
8. Sen, R., and D. Baltimore. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer. Cell 46:705.
9. Atchison, M. L., and R. P. Perry. 1987. The role of the κ enhancer and its binding factor NF-κB in the developmental regulation of κ gene transcription. Cell 48:121.
10. Scherer, D. C., J. A. Brodeman, H. H. Bendall, G. M. Zhang, D. W. Ballard, and E. M. Oltz. 1996. Compression of Re1A and c-Rel inhibits immunoglobulin κ gene transcription and rearrangement in precursor B lymphocytes. Immunity 5:563.
11. Sha, W. C., H. D. Liou, E. I. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80:321.
12. Weih, E., D. Carrasco, S. K. Durham, D.-S. Barton, C. A. R. Ryseck, S. A. Lira, and R. Bravo. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell 80:331.
13. Köntgen, F., R. J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlintou, and S. Gerondakis. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9:1965.
14. Beg, A. A., W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the Rel A component of NF-kappa B. Nature 376:167.
15. Xu, Y., L. Davidson, F. W. Alt, and D. Baltimore. 1996. Deletion of the Ig kappa light chain intron enhancer/matrix attachment region impairs but does not abolish V kappa J kappa rearrangement. Immunity 4:377.
16. Brinskin, M., M. D. Kuwabara, D. S. Sigman, and R. Wall. 1988. Induction of kappa transcription by interferon-gamma without activation of NF-kappa B. Science 242:1036.
17. Mauxion, F., C. Jamieson, M. Yoshida, K. Arai, and R. Sen. 1991. Comparison of constitutive and inducible transcriptional enhancement mediated by κB-related sequences: modulation of activity in B cells by human T-cell leukemia virus type I tax gene. Proc. Natl. Acad. Sci. USA 88:2141.
18. Maniatis, T., J. Sambrook, and E. F. Fritsch. 1989. Molecular Cloning, 2nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., Section 7.6.
19. Schlissel, M. S., and D. Baltimore. 1989. Activation of immunoglobulin kappa gene rearrangement correlates with induction of germline kappa gene transcription. Cell 58:1001.
20. Greenberg, M. E., and E. B. Ziff. 1984. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 311:433.
21. Miyamoto, S., M. J. Schmitt, and I. M. Verma. 1994. Qualitative changes in the subunit composition of kappa B-binding complexes during murine B-cell differentiation. Proc. Natl. Acad. Sci. USA 91:5056.
22. Liou, H. C., W. C. Sha, M. L. Scott, and D. Baltimore. 1994. Sequential induction of NF-kappa B/Rel family during B-cell terminal differentiation. Mol. Cell. Biol. 14:5349.
23. Kirillov, A., B. Kistler, R. Mostoslavsky, H. Cedar, T. Wirth, and Y. Bergman. 1996. A role for nuclear NF-kappa B in B-cell-specific demethylation of the Ig kappa locus. Nat. Genet. 13:435.
24. Clarke, C. J., D. A. Taylor-Fishwick, A. Hales, Y. Chemajovsky, K. Sugamura, M. Feldmann, and B. M. Faxwell. 1996. Interleukin-4 inhibits kappa light chain expression and NF kappa B activation but not I kappa B alpha degradation in 70Z/3 murine pre-B cells. Eur J. Immunol. 25:2961.
25. Alt, F., N. Rosenberg, S. Lewis, E. Thomas, and D. Baltimore. 1981. Organization and reorganization of immunoglobulin genes in A-MULV-transformed cells: rearrangement of heavy but not light chain genes. Cell 27:381.
26. κ gene. Cell 27:593.
27. Queen, C., and D. Baltimore. 1983. Immunoglobulin gene transcription is activated by downstream sequences. Cell 33:741.
28. Meyer, K. B., and M. S. Neuberger. 1989. The immunoglobulin κ locus contains a second, stronger B-cell-specific enhancer which is located downstream of the constant region. EMBO J. 8:1959.
29. Chen, Y. Y., L. C. Wang, M. S. Huang, and N. Rosenberg. 1994. An active v-ab1 protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement. Genes Dev. 8:688.
30. Klug, C. A., S. J. Gerety, P. C. Shah, Y. Y. Chen, N. R. Rice, N. Rosenberg, and H. Singh. 1995. The v-ab1 tyrosine kinase negatively regulates NF-kappa B/Rel factors and blocks kappa gene transcription in pre-B lymphocytes. Genes Dev. 8:678.
31. Naumann, M., and C. Scheidereit. 1994. Activation of NF-kappa B in vivo is regulated by multiple phosphorylation. EMBO J. 13:4597.
32. Druker, B. J., M. Neumann, K. Okuda, J. B. R. Franza, and J. D. Griffin. 1994. Rel is rapidly tyrosine-phosphorylated following granulocyte-colony stimulating faction treatment of human mitrophils. J. Biol. Chem. 269:5387.
33. Shirakawa, F., M. Chedid, J. Suttles, B. A. Pollok, and S. B. Mizel. 1989. Interleukin 1 and cyclic AMP induce kappa immunoglobulin light-chain expression via activation of an NF-kappa B-like DNA-binding protein. Mol. Cell. Biol. 9:959.
34. Mosialos, G., P. Hamer, A. J. Capobianco, R. A. Laursen, and T. D. Gilmore. 1991. A protein kinase-A recognition sequence is structurally linked to transformation by P59 v-Rel and cytoplasmic retention of P68 c-rel. Mol. Cell Biol. 11:5867.
35. Norris, J. L., and J. L. Manley. 1992. Selective nuclear transport of the Drosophila morphogen dorsal can be established by a signaling pathway involving the transmembrane protein Toll and protein kinase A. Genes Dev. 6:1654.